GSK plans to depart the biotechnology industry’s largest trade ... after Republicans took control of the White House and ...

The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...

The US group's division has reported a pre-tax profit of $39.5m (£30.6m) for the 12 months to 31 January, 2024, according to ...

Profit at the UK arm of software giant Workday almost doubled during its latest financial year, it has been revealed.

AnaptysBio has a past history of successes. There are 2 molecules in phase 2, but with no patient data. GSK news has hurt ANAB stock. Read more here.

“This could drag for some time,” said Naresh Chouhan, founder of health-care equity research house Intron Health ... have ...

A global biopharma company just announced that it will be investing up to $800 million to expand its long-time Lancaster ...

The upgraded manufacturing campus will be equipped to crank out commercial drugs and vaccines plus house an R&D pilot plant to manufacture medicines for clinical trials. GSK plans to add about 200 ...

GSK asserts that Moderna's use of LNPs to deliver ... and move my position to “house money” status. Long term, I still intend on trading MRNA and will build a core position for a long-term ...

Independent creative communications agency alt/shift/ has appointed two new General Managers to oversee its Melbourne and ...

The big pharma company GlaxoSmithKline will inject up to $800 million into its manufacturing site in Marietta, Pennsylvania, ...

The Shocking Truth" How did Zantac, once the world's most popular drug for acid reflux and heartburn, turn into a toxic ...